Status:
COMPLETED
Ultrasound Elastography of Breast Lesions
Lead Sponsor:
SuperSonic Imagine
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
21+ years
Brief Summary
Our hypothesis is that the addition of ShearWave Elastography (SWE) to a conventional breast ultrasound examination provides useful information for the radiologist when imaging lesions in the breast, ...
Eligibility Criteria
Inclusion
- patients who have been referred to a breast ultrasound because of a positive physical palpation and/or positive mammograms and/or positive ultrasound and/or positive MRI.
- female
- age 21 or older
- provide informed consent
Exclusion
- Women who are unwilling or unable to provide informed consent
- Women with breast implants
- Women with superficial lesions or lesions on skin (with the most superficial surface of the lesion within 5 mm of the skin surface)
- Women who are pregnant or breastfeeding
- Women who are undergoing chemotherapy or radiotherapy for any cancer
- Women with previous breast conserving surgery on the breast of interest Note: Previous excision of a benign lesion 4 cm or more away from the suspected lesion does not constitute an exclusion criterion.
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2010
Estimated Enrollment :
1681 Patients enrolled
Trial Details
Trial ID
NCT00716482
Start Date
July 1 2008
End Date
June 1 2010
Last Update
September 9 2013
Active Locations (16)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Southern California - LAC+USC Medical Center, OPD Rm 3P61
Los Angeles, California, United States, 90033
2
Sally Jobe Breast Center
Denver, Colorado, United States, 80206
3
Yale Medical Center, Department of Diagnostic Radiology
New Haven, Connecticut, United States, 06510
4
Northwestern Memorial Hospital, Dept. of Radiology
Chicago, Illinois, United States, 60611